Cooper Companies (NASDAQ:COO) Earns Hold Rating from Needham & Company LLC

Cooper Companies (NASDAQ:COOGet Free Report)‘s stock had its “hold” rating reiterated by equities researchers at Needham & Company LLC in a research note issued on Friday,Benzinga reports.

Several other equities analysts have also recently weighed in on COO. Morgan Stanley lowered their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Citigroup decreased their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $111.89.

View Our Latest Stock Report on Cooper Companies

Cooper Companies Stock Performance

Shares of COO stock opened at $85.00 on Friday. Cooper Companies has a one year low of $82.61 and a one year high of $112.38. The company’s 50-day moving average is $92.38 and its 200 day moving average is $99.40. The company has a market capitalization of $16.96 billion, a price-to-earnings ratio of 43.59, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COOGet Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. The business had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Sell-side analysts expect that Cooper Companies will post 3.98 EPS for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

A number of institutional investors have recently added to or reduced their stakes in COO. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Cooper Companies in the fourth quarter valued at $17,392,000. Jefferies Financial Group Inc. boosted its stake in Cooper Companies by 138.9% during the fourth quarter. Jefferies Financial Group Inc. now owns 48,514 shares of the medical device company’s stock worth $4,460,000 after buying an additional 28,204 shares during the period. Mackenzie Financial Corp boosted its stake in Cooper Companies by 12.4% during the fourth quarter. Mackenzie Financial Corp now owns 19,910 shares of the medical device company’s stock worth $1,830,000 after buying an additional 2,193 shares during the period. Forum Financial Management LP boosted its stake in Cooper Companies by 107.3% during the fourth quarter. Forum Financial Management LP now owns 3,840 shares of the medical device company’s stock worth $353,000 after buying an additional 1,988 shares during the period. Finally, Castlekeep Investment Advisors LLC bought a new stake in shares of Cooper Companies during the fourth quarter worth $685,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

(Get Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Recommended Stories

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.